$SER
Serina Therapeutics, Inc.
XASE•Health Care•Pharmaceutical Preparations
$2.25
▲+1.35%+$0.030
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateSerina Therapeutics, Inc.
XASE•Health Care•Pharmaceutical Preparations
Why is SER up today? It is at $2.25 (+1.35%), and our scanner flagged it 7 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SER spikes, and full due diligence on SER — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SER 7 times in the last 30 days. Create a free account to track $SER, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on SER from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SER today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystClinical / FDA update, from the latest SEC filing. Read it →Across every filing on file, supply equal to 28% of the tradeable float is in play - 28% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
Active shelf on file — the company can issue new shares on demand (valid ~3 years)
12,500,000 new shares
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Brannan Stephen K. Director | Bought (open market) | +1K | n/a | 1K | $2K at $2.03 | Jul 7, 26 |
Bailey Gregory Director | Acquired (grant/award) | +8.44M 33.2% of company | added 100% | 8.56M | $19.0M at $2.25 | Jun 17, 26 |
Venkatesan Jay Director | Acquired (grant/award) | +224K 0.9% of company | added 100% | 232K | $504K at $2.25 | Jun 17, 26 |
Wilson Karen J Director | Bought (open market) | +5K 0.02% of company | added 98% | 10K | $9K at $1.77 | Jun 12, 26 |
Wilson Karen J Director | Bought (open market) | +5K 0.02% of company | n/a | 5K | $9K at $1.75 | Jun 11, 26 |
Ledger Steven A Officer | Acquired (grant/award) | +10K 0.04% of company | n/a | 10K | $19K at $1.93 | May 26, 26 |
Wilson Karen J Director | Bought (open market) | +10K 0.04% of company | added 100% | 20K | $19K at $1.93 | May 22, 26 |
Venkatesan Jay Director | Bought (open market) | +589 | n/a | 589 | $1K at $1.78 | May 22, 26 |
Wilson Karen J Director | Bought (open market) | +10K 0.04% of company | n/a | 10K | $18K at $1.77 | May 21, 26 |
Marshall Richard Peter Director | Bought (open market) | +12K 0.05% of company | n/a | 12K | $20K at $1.65 | May 19, 26 |
Venkatesan Jay Director | Acquired (grant/award) | +8K 0.03% of company | n/a | 8K | $15K at $1.94 | Mar 31, 26 |
Bailey Gregory Director | Acquired (grant/award) | +60K 0.2% of company | added 89% | 127K | $116K at $1.94 | Mar 31, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on SER from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SER today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
SER last traded at $2.25, up 1.35% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Serina Therapeutics, Inc. (SER) is next expected to report earnings on Thursday, November 12, 2026, about 55 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The SER Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SER 7 times in the last 30 days.
SER (Serina Therapeutics, Inc.) trades on XASE, with a market cap of about $56M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SER for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SER discussion
Sign in to ask a question or join the discussion.